4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...
GlobalData on MSN
Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy
Japan's Ministry of Health, Labor and Welfare (MHLW) has granted orphan regenerative medicine product designation to Kyowa ...
Stempeutics India and MEDINET Japan have announced an option license agreement for Stempeucel, a cell therapy product for treating CLTI in Japan. This deal could lead to an exclusive license, allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback